

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.85279088 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.85279088 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.68187976 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.68187976 |
| 5 | protein localization to endosome (GO:0036010) | 4.16251634 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10563307 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 3.91504012 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.88167066 |
| 9 | regulation of cholesterol homeostasis (GO:2000188) | 3.83114352 |
| 10 | lysine metabolic process (GO:0006553) | 3.73647022 |
| 11 | lysine catabolic process (GO:0006554) | 3.73647022 |
| 12 | regulation of histone H3-K27 methylation (GO:0061085) | 3.71976212 |
| 13 | valine metabolic process (GO:0006573) | 3.58885593 |
| 14 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.55066877 |
| 15 | positive regulation of histone deacetylation (GO:0031065) | 3.53395749 |
| 16 | mannose metabolic process (GO:0006013) | 3.44422607 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.43729413 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 3.43729413 |
| 19 | positive regulation of nuclease activity (GO:0032075) | 3.43522566 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38998491 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.36239418 |
| 22 | nuclear pore complex assembly (GO:0051292) | 3.35502241 |
| 23 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.32475121 |
| 24 | tricarboxylic acid metabolic process (GO:0072350) | 3.30018806 |
| 25 | L-phenylalanine metabolic process (GO:0006558) | 3.28259458 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.28259458 |
| 27 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.27279376 |
| 28 | cell-substrate adherens junction assembly (GO:0007045) | 3.24286102 |
| 29 | focal adhesion assembly (GO:0048041) | 3.24286102 |
| 30 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.21373181 |
| 31 | adherens junction assembly (GO:0034333) | 3.20821969 |
| 32 | activation of Rac GTPase activity (GO:0032863) | 3.17396924 |
| 33 | * COPII vesicle coating (GO:0048208) | 3.16368245 |
| 34 | regulation of early endosome to late endosome transport (GO:2000641) | 3.15817796 |
| 35 | regulation of nuclease activity (GO:0032069) | 3.14619556 |
| 36 | 2-oxoglutarate metabolic process (GO:0006103) | 3.14552154 |
| 37 | 4-hydroxyproline metabolic process (GO:0019471) | 3.12999632 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.11867120 |
| 39 | cell-substrate junction assembly (GO:0007044) | 3.08278377 |
| 40 | urea cycle (GO:0000050) | 3.06697256 |
| 41 | urea metabolic process (GO:0019627) | 3.06697256 |
| 42 | stress fiber assembly (GO:0043149) | 3.05712066 |
| 43 | positive thymic T cell selection (GO:0045059) | 3.05226214 |
| 44 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.04067144 |
| 45 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.02996760 |
| 46 | proline biosynthetic process (GO:0006561) | 3.00237166 |
| 47 | sulfur amino acid catabolic process (GO:0000098) | 3.00014398 |
| 48 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.98694782 |
| 49 | negative regulation of cell size (GO:0045792) | 2.98032512 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 2.96646600 |
| 51 | negative regulation of sterol transport (GO:0032372) | 2.96646600 |
| 52 | kynurenine metabolic process (GO:0070189) | 2.96207682 |
| 53 | skin morphogenesis (GO:0043589) | 2.94121282 |
| 54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.93790560 |
| 55 | regulation of RNA export from nucleus (GO:0046831) | 2.91002032 |
| 56 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.90145778 |
| 57 | pinocytosis (GO:0006907) | 2.89365392 |
| 58 | cellular response to unfolded protein (GO:0034620) | 2.87816138 |
| 59 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87601089 |
| 60 | embryonic process involved in female pregnancy (GO:0060136) | 2.87546545 |
| 61 | negative regulation of fibrinolysis (GO:0051918) | 2.87079532 |
| 62 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.86881209 |
| 63 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.84999070 |
| 64 | glucose 6-phosphate metabolic process (GO:0051156) | 2.84498281 |
| 65 | ER-nucleus signaling pathway (GO:0006984) | 2.82177491 |
| 66 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.81132597 |
| 67 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.79741973 |
| 68 | complement activation, alternative pathway (GO:0006957) | 2.77851492 |
| 69 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.77379743 |
| 70 | protein retention in ER lumen (GO:0006621) | 2.75509626 |
| 71 | aromatic amino acid family catabolic process (GO:0009074) | 2.75484410 |
| 72 | maternal placenta development (GO:0001893) | 2.71012748 |
| 73 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70554384 |
| 74 | cellular response to topologically incorrect protein (GO:0035967) | 2.70355578 |
| 75 | regulation of protein activation cascade (GO:2000257) | 2.69449636 |
| 76 | * vesicle coating (GO:0006901) | 2.69033208 |
| 77 | glyoxylate metabolic process (GO:0046487) | 2.68522368 |
| 78 | intestinal cholesterol absorption (GO:0030299) | 2.68391774 |
| 79 | barbed-end actin filament capping (GO:0051016) | 2.68343209 |
| 80 | protein carboxylation (GO:0018214) | 2.67353418 |
| 81 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.67353418 |
| 82 | oxaloacetate metabolic process (GO:0006107) | 2.66283059 |
| 83 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.64018108 |
| 84 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.63857829 |
| 85 | nitrogen cycle metabolic process (GO:0071941) | 2.62826449 |
| 86 | hemidesmosome assembly (GO:0031581) | 2.62762014 |
| 87 | response to laminar fluid shear stress (GO:0034616) | 2.62759327 |
| 88 | growth hormone receptor signaling pathway (GO:0060396) | 2.61960919 |
| 89 | desmosome organization (GO:0002934) | 2.61489592 |
| 90 | cysteine metabolic process (GO:0006534) | 2.60513256 |
| 91 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.60380203 |
| 92 | negative regulation of lipid transport (GO:0032369) | 2.60082752 |
| 93 | regulation of complement activation (GO:0030449) | 2.58589604 |
| 94 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.58560395 |
| 95 | nuclear pore organization (GO:0006999) | 2.58543643 |
| 96 | mitotic chromosome condensation (GO:0007076) | 2.57721772 |
| 97 | thymic T cell selection (GO:0045061) | 2.57176535 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 2.57136832 |
| 99 | negative thymic T cell selection (GO:0045060) | 2.56849429 |
| 100 | negative T cell selection (GO:0043383) | 2.54648897 |
| 101 | modulation by symbiont of host cellular process (GO:0044068) | 2.54514410 |
| 102 | regulation of translational fidelity (GO:0006450) | 2.54203983 |
| 103 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.53784718 |
| 104 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.53080728 |
| 105 | protein export from nucleus (GO:0006611) | 2.52994752 |
| 106 | regulation of cholesterol storage (GO:0010885) | 2.52587503 |
| 107 | histone H3-K36 demethylation (GO:0070544) | 2.52403455 |
| 108 | regulation of extracellular matrix disassembly (GO:0010715) | 2.51515938 |
| 109 | positive regulation of protein deacetylation (GO:0090312) | 2.51011396 |
| 110 | pentose-phosphate shunt (GO:0006098) | 2.50989557 |
| 111 | homocysteine metabolic process (GO:0050667) | 2.50702071 |
| 112 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.50518788 |
| 113 | intestinal absorption (GO:0050892) | 2.50173342 |
| 114 | cellular modified amino acid catabolic process (GO:0042219) | 2.49999903 |
| 115 | negative regulation of viral release from host cell (GO:1902187) | 2.49537374 |
| 116 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.49479755 |
| 117 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49132735 |
| 118 | tryptophan catabolic process (GO:0006569) | 2.47261289 |
| 119 | indole-containing compound catabolic process (GO:0042436) | 2.47261289 |
| 120 | indolalkylamine catabolic process (GO:0046218) | 2.47261289 |
| 121 | membrane protein ectodomain proteolysis (GO:0006509) | 2.46691625 |
| 122 | apoptotic process involved in morphogenesis (GO:0060561) | 2.44731122 |
| 123 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.44363912 |
| 124 | NIK/NF-kappaB signaling (GO:0038061) | 2.44129705 |
| 125 | glycine metabolic process (GO:0006544) | 2.42527181 |
| 126 | high-density lipoprotein particle remodeling (GO:0034375) | 2.42151475 |
| 127 | regulation of defense response to virus by virus (GO:0050690) | 2.40847963 |
| 128 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.40839104 |
| 129 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.39798457 |
| 130 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.39787155 |
| 131 | basement membrane organization (GO:0071711) | 2.39178887 |
| 132 | pore complex assembly (GO:0046931) | 2.38549011 |
| 133 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.38413689 |
| 134 | amino-acid betaine metabolic process (GO:0006577) | 2.37863972 |
| 135 | phospholipid efflux (GO:0033700) | 2.36828920 |
| 136 | NADPH regeneration (GO:0006740) | 2.36413326 |
| 137 | regulation of triglyceride catabolic process (GO:0010896) | 2.35634999 |
| 138 | dosage compensation (GO:0007549) | 2.35418247 |
| 139 | semaphorin-plexin signaling pathway (GO:0071526) | 2.34919136 |
| 140 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.34671887 |
| 141 | phospholipid homeostasis (GO:0055091) | 2.34412128 |
| 142 | signal complex assembly (GO:0007172) | 2.34134165 |
| 143 | tryptophan metabolic process (GO:0006568) | 2.33895249 |
| 144 | serine family amino acid catabolic process (GO:0009071) | 2.33349828 |
| 145 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.32846247 |
| 146 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.31791940 |
| 147 | plasma lipoprotein particle clearance (GO:0034381) | 2.31313454 |
| 148 | response to endoplasmic reticulum stress (GO:0034976) | 2.31280101 |
| 149 | regulation of fatty acid oxidation (GO:0046320) | 2.31119840 |
| 150 | protein-lipid complex assembly (GO:0065005) | 2.30615382 |
| 151 | reverse cholesterol transport (GO:0043691) | 2.29891179 |
| 152 | response to muramyl dipeptide (GO:0032495) | 2.28567806 |
| 153 | epithelial cell-cell adhesion (GO:0090136) | 2.28260094 |
| 154 | snRNA metabolic process (GO:0016073) | 2.28038707 |
| 155 | glucose catabolic process (GO:0006007) | 2.27715812 |
| 156 | surfactant homeostasis (GO:0043129) | 2.27326340 |
| 157 | regulation of integrin activation (GO:0033623) | 2.26463598 |
| 158 | regulation of chromatin binding (GO:0035561) | 2.26055924 |
| 159 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.25841196 |
| 160 | amyloid precursor protein catabolic process (GO:0042987) | 2.24426491 |
| 161 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.23459934 |
| 162 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.23449949 |
| 163 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.23204259 |
| 164 | hypotonic response (GO:0006971) | 2.23017137 |
| 165 | negative regulation of fatty acid transport (GO:2000192) | 2.22942513 |
| 166 | modulation by virus of host process (GO:0019054) | 2.21438604 |
| 167 | mammary gland epithelial cell proliferation (GO:0033598) | 2.20810272 |
| 168 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.20322394 |
| 169 | protein localization to microtubule (GO:0035372) | 2.19734613 |
| 170 | cortical actin cytoskeleton organization (GO:0030866) | 2.19555287 |
| 171 | germinal center formation (GO:0002467) | 2.19399824 |
| 172 | cell adhesion mediated by integrin (GO:0033627) | 2.19079137 |
| 173 | NADH metabolic process (GO:0006734) | 2.18421907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.51644739 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.33201456 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.32021510 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.30257884 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.24176543 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.17165859 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.68444365 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.60344115 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.45553646 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.30808169 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.18571803 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.12355907 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01633119 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00180421 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.93211193 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89130578 |
| 17 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.86994391 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.86457913 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.83313066 |
| 20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81593099 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.79003814 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78663473 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75516970 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75471799 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72417578 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72281296 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68912945 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66042628 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.65489896 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62207389 |
| 31 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61071080 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58201300 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58087005 |
| 34 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.57762611 |
| 35 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55083733 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52461414 |
| 37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50328675 |
| 38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.47231064 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.44880608 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.44384064 |
| 41 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.42666165 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42170217 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41764194 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.38414904 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38331681 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.37998816 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.37208583 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35161706 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35147458 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33430143 |
| 51 | ATF3_27146783_Chip-Seq_COLON_Human | 1.33082679 |
| 52 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.32877315 |
| 53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32761533 |
| 54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31887029 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31563782 |
| 56 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30665472 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30226806 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.30116500 |
| 59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29777635 |
| 60 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29452997 |
| 61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28588191 |
| 62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.27813673 |
| 63 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27326217 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26581516 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26500669 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26463929 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26370201 |
| 68 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26133644 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.25311596 |
| 70 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24251843 |
| 71 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.23055571 |
| 72 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.21982574 |
| 73 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21009905 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19523036 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19107933 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16948502 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16410511 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16351415 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16167399 |
| 80 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15324492 |
| 81 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15191739 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14712745 |
| 83 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14708974 |
| 84 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.14152720 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13775391 |
| 86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12770433 |
| 87 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11638890 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.11204862 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10795586 |
| 90 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09440618 |
| 91 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09081878 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08117399 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07841557 |
| 94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07559900 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07249257 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06757145 |
| 97 | * MAF_26560356_Chip-Seq_TH2_Human | 1.06705491 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06028354 |
| 99 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05892925 |
| 100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04025397 |
| 101 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04002917 |
| 102 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.03797524 |
| 103 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03666278 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03282717 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03214183 |
| 106 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.02558042 |
| 107 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01450456 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.01303711 |
| 109 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01140578 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00953897 |
| 111 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00899939 |
| 112 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00873947 |
| 113 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00620660 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99870335 |
| 115 | P68_20966046_ChIP-Seq_HELA_Human | 0.98614771 |
| 116 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98361072 |
| 117 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97898137 |
| 118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97868901 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97402627 |
| 120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97402627 |
| 121 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96675291 |
| 122 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95669977 |
| 123 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95583396 |
| 124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94324995 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93968119 |
| 126 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.93625634 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93308164 |
| 128 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92769087 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92602246 |
| 130 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.91541188 |
| 131 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90616509 |
| 132 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90204307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.40633138 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.40431321 |
| 3 | MP0005360_urolithiasis | 3.39017526 |
| 4 | MP0005365_abnormal_bile_salt | 3.20244846 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.14000004 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.71419346 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.39476947 |
| 8 | MP0003252_abnormal_bile_duct | 2.38796123 |
| 9 | MP0009840_abnormal_foam_cell | 2.31277450 |
| 10 | MP0008260_abnormal_autophagy | 2.25238097 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.18128909 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.08612007 |
| 13 | MP0003091_abnormal_cell_migration | 2.05366993 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.04230406 |
| 15 | MP0000537_abnormal_urethra_morphology | 1.97797907 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 1.94798321 |
| 17 | MP0001666_abnormal_nutrient_absorption | 1.88019662 |
| 18 | MP0010329_abnormal_lipoprotein_level | 1.87533295 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.81838830 |
| 20 | MP0005076_abnormal_cell_differentiation | 1.80907505 |
| 21 | MP0003453_abnormal_keratinocyte_physiol | 1.76392841 |
| 22 | MP0008961_abnormal_basal_metabolism | 1.74011250 |
| 23 | MP0002796_impaired_skin_barrier | 1.74003459 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.68486194 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.66724847 |
| 26 | MP0000609_abnormal_liver_physiology | 1.66234252 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.56174884 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.55506467 |
| 29 | MP0001348_abnormal_lacrimal_gland | 1.52237082 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.50714306 |
| 31 | MP0000685_abnormal_immune_system | 1.47616458 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.45254957 |
| 33 | MP0005083_abnormal_biliary_tract | 1.44235337 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.41658040 |
| 35 | MP0004947_skin_inflammation | 1.35751993 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.32244854 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.29935999 |
| 38 | MP0005220_abnormal_exocrine_pancreas | 1.29899630 |
| 39 | MP0005409_darkened_coat_color | 1.29689217 |
| 40 | MP0005501_abnormal_skin_physiology | 1.28965611 |
| 41 | MP0006054_spinal_hemorrhage | 1.28015433 |
| 42 | MP0003436_decreased_susceptibility_to | 1.27324519 |
| 43 | MP0002060_abnormal_skin_morphology | 1.26726374 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.26070689 |
| 45 | MP0001849_ear_inflammation | 1.24980705 |
| 46 | MP0003329_amyloid_beta_deposits | 1.22713116 |
| 47 | MP0001216_abnormal_epidermal_layer | 1.20870116 |
| 48 | MP0004858_abnormal_nervous_system | 1.20546303 |
| 49 | MP0005621_abnormal_cell_physiology | 1.20258956 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.18747565 |
| 51 | MP0005023_abnormal_wound_healing | 1.17224311 |
| 52 | MP0004272_abnormal_basement_membrane | 1.12316869 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.11672173 |
| 54 | MP0003868_abnormal_feces_composition | 1.11176920 |
| 55 | MP0000598_abnormal_liver_morphology | 1.10779843 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.09374840 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.08351219 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.07566010 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.06773354 |
| 60 | MP0005000_abnormal_immune_tolerance | 1.04879274 |
| 61 | MP0004130_abnormal_muscle_cell | 1.04806331 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.03259120 |
| 63 | MP0009278_abnormal_bone_marrow | 1.02844052 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.01379420 |
| 65 | MP0005332_abnormal_amino_acid | 1.01374301 |
| 66 | MP0005666_abnormal_adipose_tissue | 1.00349153 |
| 67 | MP0005375_adipose_tissue_phenotype | 0.98573124 |
| 68 | MP0001873_stomach_inflammation | 0.98368942 |
| 69 | MP0001790_abnormal_immune_system | 0.97699112 |
| 70 | MP0005387_immune_system_phenotype | 0.97699112 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97097984 |
| 72 | MP0005257_abnormal_intraocular_pressure | 0.96994041 |
| 73 | MP0002419_abnormal_innate_immunity | 0.96938266 |
| 74 | MP0003111_abnormal_nucleus_morphology | 0.96723115 |
| 75 | MP0009931_abnormal_skin_appearance | 0.96406133 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.95318422 |
| 77 | MP0005025_abnormal_response_to | 0.94054224 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.93657940 |
| 79 | MP0001800_abnormal_humoral_immune | 0.93324832 |
| 80 | MP0001756_abnormal_urination | 0.93204486 |
| 81 | MP0000490_abnormal_crypts_of | 0.92945330 |
| 82 | MP0002006_tumorigenesis | 0.92650624 |
| 83 | MP0001944_abnormal_pancreas_morphology | 0.92433794 |
| 84 | MP0009672_abnormal_birth_weight | 0.92304119 |
| 85 | MP0000013_abnormal_adipose_tissue | 0.91538064 |
| 86 | MP0001533_abnormal_skeleton_physiology | 0.90841466 |
| 87 | MP0003303_peritoneal_inflammation | 0.89619845 |
| 88 | MP0001853_heart_inflammation | 0.87830384 |
| 89 | MP0005623_abnormal_meninges_morphology | 0.87402503 |
| 90 | MP0002080_prenatal_lethality | 0.87350441 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.87311731 |
| 92 | MP0000350_abnormal_cell_proliferation | 0.87227430 |
| 93 | MP0002398_abnormal_bone_marrow | 0.86952094 |
| 94 | MP0003283_abnormal_digestive_organ | 0.86145836 |
| 95 | MP0000467_abnormal_esophagus_morphology | 0.85124260 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.84807560 |
| 97 | MP0001730_embryonic_growth_arrest | 0.84552161 |
| 98 | MP0003195_calcinosis | 0.84086173 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.83904779 |
| 100 | MP0004197_abnormal_fetal_growth/weight/ | 0.83904317 |
| 101 | MP0009333_abnormal_splenocyte_physiolog | 0.83538910 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.83266792 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.83133696 |
| 104 | MP0002086_abnormal_extraembryonic_tissu | 0.81677885 |
| 105 | MP0005384_cellular_phenotype | 0.81149307 |
| 106 | MP0002088_abnormal_embryonic_growth/wei | 0.80835791 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.80305809 |
| 108 | MP0000767_abnormal_smooth_muscle | 0.80166459 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.80037777 |
| 110 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79611500 |
| 111 | MP0001835_abnormal_antigen_presentation | 0.79555478 |
| 112 | MP0002452_abnormal_antigen_presenting | 0.79528285 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.79377465 |
| 114 | MP0001819_abnormal_immune_cell | 0.79157462 |
| 115 | MP0005670_abnormal_white_adipose | 0.79105069 |
| 116 | MP0002420_abnormal_adaptive_immunity | 0.78933387 |
| 117 | MP0003448_altered_tumor_morphology | 0.78904423 |
| 118 | MP0000377_abnormal_hair_follicle | 0.78888436 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.78837872 |
| 120 | MP0003866_abnormal_defecation | 0.78674485 |
| 121 | MP0000604_amyloidosis | 0.78639368 |
| 122 | MP0003984_embryonic_growth_retardation | 0.78629387 |
| 123 | MP0001958_emphysema | 0.78332919 |
| 124 | MP0002723_abnormal_immune_serum | 0.78328817 |
| 125 | MP0010630_abnormal_cardiac_muscle | 0.76743412 |
| 126 | MP0005380_embryogenesis_phenotype | 0.76739833 |
| 127 | MP0001672_abnormal_embryogenesis/_devel | 0.76739833 |
| 128 | MP0002098_abnormal_vibrissa_morphology | 0.76199932 |
| 129 | MP0010307_abnormal_tumor_latency | 0.75196925 |
| 130 | MP0004510_myositis | 0.75113711 |
| 131 | MP0002269_muscular_atrophy | 0.74631390 |
| 132 | MP0005275_abnormal_skin_tensile | 0.74204774 |
| 133 | MP0002693_abnormal_pancreas_physiology | 0.74168903 |
| 134 | MP0002254_reproductive_system_inflammat | 0.74041592 |
| 135 | MP0009053_abnormal_anal_canal | 0.73898989 |
| 136 | MP0002928_abnormal_bile_duct | 0.73732990 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.73305070 |
| 138 | MP0003172_abnormal_lysosome_physiology | 0.73212013 |
| 139 | MP0002722_abnormal_immune_system | 0.72713777 |
| 140 | MP0008469_abnormal_protein_level | 0.72290800 |
| 141 | MP0000716_abnormal_immune_system | 0.72135800 |
| 142 | MP0005671_abnormal_response_to | 0.71470228 |
| 143 | MP0000858_altered_metastatic_potential | 0.71467351 |
| 144 | MP0002970_abnormal_white_adipose | 0.71102807 |
| 145 | MP0000477_abnormal_intestine_morphology | 0.70395303 |
| 146 | MP0000689_abnormal_spleen_morphology | 0.69644700 |
| 147 | MP0001915_intracranial_hemorrhage | 0.68480647 |
| 148 | MP0002429_abnormal_blood_cell | 0.68438081 |
| 149 | MP0004233_abnormal_muscle_weight | 0.68129035 |
| 150 | MP0000733_abnormal_muscle_development | 0.67986053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 3.68584348 |
| 2 | Hypoglycemic coma (HP:0001325) | 3.43674201 |
| 3 | Xanthomatosis (HP:0000991) | 2.90555540 |
| 4 | Broad face (HP:0000283) | 2.89770759 |
| 5 | Abnormal gallbladder physiology (HP:0012438) | 2.87950552 |
| 6 | Cholecystitis (HP:0001082) | 2.87950552 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.86020280 |
| 8 | Premature rupture of membranes (HP:0001788) | 2.85124956 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 2.82310745 |
| 10 | Vertebral compression fractures (HP:0002953) | 2.77440158 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 2.73193141 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.72862345 |
| 13 | Ankyloglossia (HP:0010296) | 2.64254623 |
| 14 | Cerebral aneurysm (HP:0004944) | 2.63079031 |
| 15 | Ketosis (HP:0001946) | 2.59331375 |
| 16 | Increased connective tissue (HP:0009025) | 2.58394653 |
| 17 | Distal lower limb amyotrophy (HP:0008944) | 2.57424736 |
| 18 | Long toe (HP:0010511) | 2.56249430 |
| 19 | Ketoacidosis (HP:0001993) | 2.47511597 |
| 20 | Hypoglycemic seizures (HP:0002173) | 2.44476023 |
| 21 | Mitral stenosis (HP:0001718) | 2.43935336 |
| 22 | Complement deficiency (HP:0004431) | 2.42266570 |
| 23 | Abnormality of oral frenula (HP:0000190) | 2.40891272 |
| 24 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.40699834 |
| 25 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.40699834 |
| 26 | Late onset (HP:0003584) | 2.40668420 |
| 27 | Hyperacusis (HP:0010780) | 2.40100430 |
| 28 | Aneurysm (HP:0002617) | 2.36000977 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 2.34217378 |
| 30 | Eczematoid dermatitis (HP:0000976) | 2.31909842 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.25866347 |
| 32 | Aortic aneurysm (HP:0004942) | 2.25696941 |
| 33 | Hypobetalipoproteinemia (HP:0003563) | 2.25089482 |
| 34 | Hand muscle atrophy (HP:0009130) | 2.24257869 |
| 35 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.21238357 |
| 36 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18980983 |
| 37 | Esophageal varix (HP:0002040) | 2.18570625 |
| 38 | Disproportionate tall stature (HP:0001519) | 2.18460667 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.16314448 |
| 40 | Hyperammonemia (HP:0001987) | 2.15510458 |
| 41 | Achilles tendon contracture (HP:0001771) | 2.12726450 |
| 42 | Hyperglycemia (HP:0003074) | 2.10831177 |
| 43 | Abnormality of the fingertips (HP:0001211) | 2.10768748 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.10633253 |
| 45 | Myocardial infarction (HP:0001658) | 2.09501597 |
| 46 | Spastic diplegia (HP:0001264) | 2.08861722 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.07623820 |
| 48 | Osteolytic defects of the hand bones (HP:0009699) | 2.06587497 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.06587497 |
| 50 | Lymphangioma (HP:0100764) | 2.06582701 |
| 51 | Reticulocytosis (HP:0001923) | 2.05342375 |
| 52 | Asymmetry of the thorax (HP:0001555) | 2.02176297 |
| 53 | Insidious onset (HP:0003587) | 2.01606739 |
| 54 | Termporal pattern (HP:0011008) | 2.01606739 |
| 55 | Distal upper limb amyotrophy (HP:0007149) | 2.01525717 |
| 56 | Upper limb amyotrophy (HP:0009129) | 2.01525717 |
| 57 | Short nail (HP:0001799) | 2.01188204 |
| 58 | Back pain (HP:0003418) | 2.00200478 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.00014478 |
| 60 | Long palpebral fissure (HP:0000637) | 1.99012082 |
| 61 | Cellulitis (HP:0100658) | 1.98678959 |
| 62 | Polycythemia (HP:0001901) | 1.98600331 |
| 63 | Gout (HP:0001997) | 1.98278689 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 1.97960486 |
| 65 | T lymphocytopenia (HP:0005403) | 1.97816409 |
| 66 | Colitis (HP:0002583) | 1.96855482 |
| 67 | Metaphyseal cupping (HP:0003021) | 1.95293861 |
| 68 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.93428803 |
| 69 | Insomnia (HP:0100785) | 1.91110896 |
| 70 | Arterial tortuosity (HP:0005116) | 1.90838518 |
| 71 | Abnormality of purine metabolism (HP:0004352) | 1.90070667 |
| 72 | Protrusio acetabuli (HP:0003179) | 1.89971173 |
| 73 | Distal lower limb muscle weakness (HP:0009053) | 1.89693611 |
| 74 | Abnormality of T cell number (HP:0011839) | 1.88675945 |
| 75 | Thin bony cortex (HP:0002753) | 1.88481946 |
| 76 | Hyperlipoproteinemia (HP:0010980) | 1.87793929 |
| 77 | Mucopolysacchariduria (HP:0008155) | 1.87715004 |
| 78 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87715004 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 1.87527014 |
| 80 | Advanced eruption of teeth (HP:0006288) | 1.87285582 |
| 81 | Nasal polyposis (HP:0100582) | 1.87202206 |
| 82 | Fragile skin (HP:0001030) | 1.86992734 |
| 83 | Ulnar bowing (HP:0003031) | 1.86406910 |
| 84 | Recurrent viral infections (HP:0004429) | 1.84079081 |
| 85 | Abnormality of complement system (HP:0005339) | 1.84009796 |
| 86 | Abnormality of the nasal mucosa (HP:0000433) | 1.83980272 |
| 87 | Pseudobulbar signs (HP:0002200) | 1.83640177 |
| 88 | Abnormality of macrophages (HP:0004311) | 1.83118254 |
| 89 | Myoglobinuria (HP:0002913) | 1.82059051 |
| 90 | Hepatocellular carcinoma (HP:0001402) | 1.81139020 |
| 91 | Right ventricular cardiomyopathy (HP:0011663) | 1.81012240 |
| 92 | Increased IgE level (HP:0003212) | 1.79678460 |
| 93 | Cerebral inclusion bodies (HP:0100314) | 1.79567783 |
| 94 | Rectal prolapse (HP:0002035) | 1.78296035 |
| 95 | Abnormal foot bone ossification (HP:0010675) | 1.78201665 |
| 96 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.78117378 |
| 97 | Mitral valve prolapse (HP:0001634) | 1.78095597 |
| 98 | Severe short stature (HP:0003510) | 1.77397636 |
| 99 | Limb hypertonia (HP:0002509) | 1.77120646 |
| 100 | Flat acetabular roof (HP:0003180) | 1.77104810 |
| 101 | Dysmetric saccades (HP:0000641) | 1.76768079 |
| 102 | Insulin resistance (HP:0000855) | 1.75171162 |
| 103 | Hypolipoproteinemia (HP:0010981) | 1.74767696 |
| 104 | Hyperglycinuria (HP:0003108) | 1.74219981 |
| 105 | Hypertensive crisis (HP:0100735) | 1.73548700 |
| 106 | Upper motor neuron abnormality (HP:0002127) | 1.73150552 |
| 107 | Abnormality of the thoracic spine (HP:0100711) | 1.72996713 |
| 108 | Cervical subluxation (HP:0003308) | 1.72628948 |
| 109 | Symptomatic seizures (HP:0011145) | 1.72399484 |
| 110 | Obstructive sleep apnea (HP:0002870) | 1.71715096 |
| 111 | Blue sclerae (HP:0000592) | 1.71511940 |
| 112 | Vascular tortuosity (HP:0004948) | 1.71391610 |
| 113 | Spontaneous hematomas (HP:0007420) | 1.70507153 |
| 114 | Increased density of long bones (HP:0006392) | 1.69517018 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.69462752 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.69462752 |
| 117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.69462752 |
| 118 | Atrophic scars (HP:0001075) | 1.69374788 |
| 119 | Hematochezia (HP:0002573) | 1.68399880 |
| 120 | Bone pain (HP:0002653) | 1.68226849 |
| 121 | Macroorchidism (HP:0000053) | 1.68198813 |
| 122 | Striae distensae (HP:0001065) | 1.68146671 |
| 123 | Loss of speech (HP:0002371) | 1.67808731 |
| 124 | Hypoplasia of the thymus (HP:0000778) | 1.67156757 |
| 125 | Gastrointestinal inflammation (HP:0004386) | 1.65893794 |
| 126 | Epidermoid cyst (HP:0200040) | 1.65869791 |
| 127 | Skin nodule (HP:0200036) | 1.65075728 |
| 128 | Gastrointestinal stroma tumor (HP:0100723) | 1.64792536 |
| 129 | Fatigue (HP:0012378) | 1.64246084 |
| 130 | Hypercholesterolemia (HP:0003124) | 1.63627377 |
| 131 | Spinal rigidity (HP:0003306) | 1.63498338 |
| 132 | Sparse lateral eyebrow (HP:0005338) | 1.63380460 |
| 133 | Cardiomegaly (HP:0001640) | 1.62933802 |
| 134 | Asymmetric septal hypertrophy (HP:0001670) | 1.62690082 |
| 135 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.62291623 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.62126321 |
| 137 | Lower limb amyotrophy (HP:0007210) | 1.61608193 |
| 138 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.61607078 |
| 139 | Abnormal ossification of hand bones (HP:0005921) | 1.61547821 |
| 140 | Trismus (HP:0000211) | 1.61475112 |
| 141 | Slow saccadic eye movements (HP:0000514) | 1.61396211 |
| 142 | Natal tooth (HP:0000695) | 1.61348416 |
| 143 | Subacute progressive viral hepatitis (HP:0006572) | 1.61147023 |
| 144 | Abnormality of nucleobase metabolism (HP:0010932) | 1.60538368 |
| 145 | Wormian bones (HP:0002645) | 1.60444460 |
| 146 | Increased mean platelet volume (HP:0011877) | 1.59848126 |
| 147 | Papilloma (HP:0012740) | 1.59772732 |
| 148 | Verrucae (HP:0200043) | 1.59772732 |
| 149 | Hypoalphalipoproteinemia (HP:0003233) | 1.59510976 |
| 150 | Flattened epiphyses (HP:0003071) | 1.59168288 |
| 151 | Patellar dislocation (HP:0002999) | 1.59098275 |
| 152 | Fat malabsorption (HP:0002630) | 1.58611981 |
| 153 | J-shaped sella turcica (HP:0002680) | 1.58556781 |
| 154 | Elfin facies (HP:0004428) | 1.58507117 |
| 155 | Progressive hearing impairment (HP:0001730) | 1.58316229 |
| 156 | Abnormality of carpal bone ossification (HP:0006257) | 1.58115419 |
| 157 | Recurrent bronchitis (HP:0002837) | 1.57812581 |
| 158 | Bowel incontinence (HP:0002607) | 1.57245437 |
| 159 | Hemorrhage of the eye (HP:0011885) | 1.56937875 |
| 160 | Decreased motor nerve conduction velocity (HP:0003431) | 1.56567281 |
| 161 | Neoplasm of the heart (HP:0100544) | 1.56464967 |
| 162 | Orthostatic hypotension (HP:0001278) | 1.56202114 |
| 163 | Cholelithiasis (HP:0001081) | 1.56067259 |
| 164 | Dilatation of the ascending aorta (HP:0005111) | 1.56066462 |
| 165 | Renovascular hypertension (HP:0100817) | 1.55734917 |
| 166 | Thrombocytosis (HP:0001894) | 1.55652962 |
| 167 | Emphysema (HP:0002097) | 1.53847708 |
| 168 | Abnormal tarsal ossification (HP:0008369) | 1.52201598 |
| 169 | Seborrheic dermatitis (HP:0001051) | 1.52100065 |
| 170 | Abnormality of the acetabulum (HP:0003170) | 1.51368118 |
| 171 | Abnormality of nail color (HP:0100643) | 1.51296716 |
| 172 | Neurofibrillary tangles (HP:0002185) | 1.51158176 |
| 173 | Persistence of primary teeth (HP:0006335) | 1.50776889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.63813749 |
| 2 | TRIB3 | 4.28103744 |
| 3 | PKN2 | 3.76421757 |
| 4 | PRPF4B | 3.49641401 |
| 5 | EEF2K | 3.25383939 |
| 6 | MAP3K10 | 3.10494296 |
| 7 | SMG1 | 3.01869307 |
| 8 | SIK1 | 2.72912221 |
| 9 | FGFR4 | 2.68000742 |
| 10 | MAP4K1 | 2.64519779 |
| 11 | IRAK3 | 2.47084123 |
| 12 | PTK6 | 2.43415873 |
| 13 | PASK | 1.99547681 |
| 14 | CDK12 | 1.92549069 |
| 15 | TTN | 1.90102703 |
| 16 | MST1R | 1.89681995 |
| 17 | FLT3 | 1.81976708 |
| 18 | RIPK4 | 1.75248057 |
| 19 | STK10 | 1.62695974 |
| 20 | TAOK3 | 1.60845716 |
| 21 | JAK3 | 1.59242281 |
| 22 | LRRK2 | 1.57487393 |
| 23 | ZAP70 | 1.54158668 |
| 24 | TYK2 | 1.47756684 |
| 25 | PDGFRA | 1.46459451 |
| 26 | BCKDK | 1.46271499 |
| 27 | NME2 | 1.45431241 |
| 28 | MAP3K14 | 1.43272220 |
| 29 | RIPK1 | 1.42730002 |
| 30 | EPHB1 | 1.37247493 |
| 31 | LATS1 | 1.30021238 |
| 32 | CAMK1G | 1.25800914 |
| 33 | ICK | 1.23445929 |
| 34 | MTOR | 1.21936559 |
| 35 | JAK1 | 1.16576472 |
| 36 | ITK | 1.13536548 |
| 37 | MAP2K3 | 1.11662362 |
| 38 | MAP3K7 | 1.11365853 |
| 39 | TAOK2 | 1.06143366 |
| 40 | FGFR3 | 1.06079826 |
| 41 | SCYL2 | 1.05222678 |
| 42 | TBK1 | 1.03541753 |
| 43 | EPHA3 | 1.03244845 |
| 44 | CDK4 | 1.01624971 |
| 45 | PTK2 | 0.98427026 |
| 46 | EIF2AK1 | 0.97845350 |
| 47 | GRK6 | 0.97135029 |
| 48 | CDK6 | 0.96339323 |
| 49 | JAK2 | 0.95710067 |
| 50 | PRKD2 | 0.95390428 |
| 51 | CAMK1D | 0.95288709 |
| 52 | LMTK2 | 0.94744320 |
| 53 | SIK2 | 0.91159810 |
| 54 | CDC42BPA | 0.90422352 |
| 55 | BTK | 0.90110057 |
| 56 | NEK2 | 0.86674196 |
| 57 | KDR | 0.85552167 |
| 58 | MARK2 | 0.84986370 |
| 59 | PAK4 | 0.84899169 |
| 60 | SIK3 | 0.82465144 |
| 61 | PDPK1 | 0.82107033 |
| 62 | MAPKAPK3 | 0.81913729 |
| 63 | MAP3K2 | 0.79404855 |
| 64 | MAPK11 | 0.78482141 |
| 65 | CSK | 0.78326457 |
| 66 | LATS2 | 0.75591911 |
| 67 | RPS6KB2 | 0.75083194 |
| 68 | PDGFRB | 0.74619155 |
| 69 | PRKCH | 0.73069014 |
| 70 | BRD4 | 0.73044781 |
| 71 | PAK2 | 0.72102076 |
| 72 | TGFBR1 | 0.71338673 |
| 73 | RET | 0.70659346 |
| 74 | ALK | 0.70423162 |
| 75 | MAPK15 | 0.70227045 |
| 76 | IRAK4 | 0.68107824 |
| 77 | ARAF | 0.67852696 |
| 78 | STK3 | 0.66075764 |
| 79 | CLK1 | 0.65913949 |
| 80 | DYRK1B | 0.65702512 |
| 81 | NTRK1 | 0.64888595 |
| 82 | TGFBR2 | 0.64027127 |
| 83 | FGFR1 | 0.63870749 |
| 84 | DDR2 | 0.63805843 |
| 85 | TAOK1 | 0.62896018 |
| 86 | CHUK | 0.62569402 |
| 87 | INSRR | 0.62552144 |
| 88 | RAF1 | 0.62140331 |
| 89 | CSF1R | 0.61357189 |
| 90 | MAP3K8 | 0.60113439 |
| 91 | STK38 | 0.59042221 |
| 92 | FRK | 0.58291502 |
| 93 | TESK1 | 0.57834711 |
| 94 | EPHA2 | 0.55628968 |
| 95 | PDK1 | 0.55560292 |
| 96 | MAP3K6 | 0.54630834 |
| 97 | HIPK2 | 0.54421318 |
| 98 | KIT | 0.52936625 |
| 99 | ERBB2 | 0.52163008 |
| 100 | KSR1 | 0.51231337 |
| 101 | RPS6KA2 | 0.50464001 |
| 102 | CDK7 | 0.50313170 |
| 103 | PRKD3 | 0.50128808 |
| 104 | BLK | 0.47557620 |
| 105 | DMPK | 0.47012972 |
| 106 | MAP3K1 | 0.46847886 |
| 107 | MAP3K3 | 0.46274121 |
| 108 | IKBKE | 0.46152898 |
| 109 | TYRO3 | 0.45873220 |
| 110 | RPS6KA4 | 0.45437562 |
| 111 | FGR | 0.43727581 |
| 112 | MAP3K13 | 0.42854027 |
| 113 | HCK | 0.41191644 |
| 114 | BMX | 0.41158045 |
| 115 | MOS | 0.40535841 |
| 116 | LCK | 0.40093321 |
| 117 | MAP2K2 | 0.39795230 |
| 118 | PIK3CG | 0.39408329 |
| 119 | TESK2 | 0.39285291 |
| 120 | TRPM7 | 0.39028835 |
| 121 | MAP3K9 | 0.37324143 |
| 122 | SYK | 0.35968837 |
| 123 | CDK9 | 0.35792951 |
| 124 | EGFR | 0.34741512 |
| 125 | YES1 | 0.34661400 |
| 126 | ILK | 0.34048856 |
| 127 | NEK9 | 0.33590581 |
| 128 | TXK | 0.33470790 |
| 129 | KSR2 | 0.33434775 |
| 130 | MAPKAPK2 | 0.33026164 |
| 131 | IRAK2 | 0.33020377 |
| 132 | RPS6KC1 | 0.32559742 |
| 133 | MARK3 | 0.31776706 |
| 134 | PAK3 | 0.31427266 |
| 135 | NEK1 | 0.31331455 |
| 136 | PRKD1 | 0.29475200 |
| 137 | MET | 0.28324643 |
| 138 | PRKAA1 | 0.28323998 |
| 139 | RPS6KA1 | 0.28263261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.84275047 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.53396083 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47611774 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.35948828 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27172846 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.24943564 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20165484 |
| 8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.08734625 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04865594 |
| 10 | Lysine degradation_Homo sapiens_hsa00310 | 1.88982425 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.78424768 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76333169 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.73447787 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69453861 |
| 15 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.59661793 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.59438388 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58045713 |
| 18 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.57261478 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.55939069 |
| 20 | Thyroid cancer_Homo sapiens_hsa05216 | 1.50306769 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.50294606 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47084295 |
| 23 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.47022311 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.46902392 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46509631 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39503619 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.22770494 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22650340 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20469556 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.20103138 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.19103344 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18636407 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.18410287 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17129025 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.15918833 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15484499 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15253830 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15007968 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14670759 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13071010 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08667299 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.07821896 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07298928 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.05167315 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.02013020 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01435828 |
| 47 | Prostate cancer_Homo sapiens_hsa05215 | 1.01249169 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00130531 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99422395 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99275705 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 0.96887639 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95300721 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94171342 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94096513 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93121792 |
| 56 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.91120987 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.90835686 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90194842 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90078990 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89610216 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89253053 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89180224 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88557626 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88156126 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87438111 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85712970 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.84526100 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.82875021 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82849854 |
| 70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82167107 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81825808 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80783568 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80681768 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80235206 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.80102786 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79331427 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79227128 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78749698 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76699826 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76276074 |
| 81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76204823 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75813023 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.75048943 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74559911 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74173733 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73690572 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73545564 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73541247 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73381770 |
| 90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73077781 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72527374 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72307415 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71882094 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71177084 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71090641 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70915693 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.70671912 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70670775 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70445538 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69950654 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.69649872 |
| 102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69269084 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69183621 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68662984 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.67988306 |
| 106 | Measles_Homo sapiens_hsa05162 | 0.66706588 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66066796 |
| 108 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65973543 |
| 109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65264400 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63552098 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62426339 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62116804 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60593726 |
| 114 | Leishmaniasis_Homo sapiens_hsa05140 | 0.60443151 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.59509895 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.59425856 |
| 117 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59157059 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59055220 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58791844 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57774388 |
| 121 | Hepatitis B_Homo sapiens_hsa05161 | 0.57418159 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56620290 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56236763 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55638784 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.55510387 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53392060 |
| 127 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52511441 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.52016897 |
| 129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51067020 |
| 130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50647757 |
| 131 | Platelet activation_Homo sapiens_hsa04611 | 0.50371882 |
| 132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50088283 |
| 133 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49397787 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48585217 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.48520884 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48517763 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48114090 |
| 138 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47956754 |
| 139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47721694 |
| 140 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47290419 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47040749 |
| 142 | Hepatitis C_Homo sapiens_hsa05160 | 0.46580802 |
| 143 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45683697 |

